XML 65 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Net sales $ 2,214,956us-gaap_SalesRevenueNet $ 1,515,139us-gaap_SalesRevenueNet $ 1,126,943us-gaap_SalesRevenueNet
Cost of goods sold (2,074,817)us-gaap_CostOfGoodsSold (1,426,112)us-gaap_CostOfGoodsSold (1,057,608)us-gaap_CostOfGoodsSold
Gross profit 140,139us-gaap_GrossProfit 89,027us-gaap_GrossProfit 69,335us-gaap_GrossProfit
Selling, general and administrative expenses (127,556)us-gaap_SellingGeneralAndAdministrativeExpense (77,944)us-gaap_SellingGeneralAndAdministrativeExpense (64,392)us-gaap_SellingGeneralAndAdministrativeExpense
Income from operations 12,583us-gaap_OperatingIncomeLoss 11,083us-gaap_OperatingIncomeLoss 4,943us-gaap_OperatingIncomeLoss
Other income (expense):      
Interest expense (2,528)us-gaap_InterestExpense (1,996)us-gaap_InterestExpense (1,086)us-gaap_InterestExpense
Change in fair value of redeemable common shares 9,073us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment (34,348)us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment (6,566)us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment
Termination of existing stock redemption agreement (4,842)dplo_TerminationOfExistingStockRedemptionAgreement    
Equity loss and impairment of non-consolidated entities (6,208)us-gaap_IncomeLossFromEquityMethodInvestments (1,055)us-gaap_IncomeLossFromEquityMethodInvestments (267)us-gaap_IncomeLossFromEquityMethodInvestments
Other 1,128us-gaap_OtherNonoperatingIncome 196us-gaap_OtherNonoperatingIncome 337us-gaap_OtherNonoperatingIncome
Total other income (expense) (3,377)us-gaap_NonoperatingIncomeExpense (37,203)us-gaap_NonoperatingIncomeExpense (7,582)us-gaap_NonoperatingIncomeExpense
Income (loss) before income taxes 9,206us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (26,120)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (2,639)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense (4,655)us-gaap_IncomeTaxExpenseBenefit    
Net income (loss) 4,551us-gaap_ProfitLoss (26,120)us-gaap_ProfitLoss (2,639)us-gaap_ProfitLoss
Less: net loss attributable to noncontrolling interest (225)us-gaap_NetIncomeLossAttributableToNoncontrollingInterest    
Net income (loss) attributable to Diplomat Pharmacy, Inc. 4,776us-gaap_NetIncomeLoss (26,120)us-gaap_NetIncomeLoss (2,639)us-gaap_NetIncomeLoss
Net income allocable to preferred shareholders 458dplo_NetIncomeLossAvailableToPreferredStockholders    
Net income (loss) allocable to common shareholders 4,318us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic (26,120)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic (2,639)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
Net income (loss) per common share:      
Basic (in dollars per share) $ 0.12us-gaap_EarningsPerShareBasic $ (0.79)us-gaap_EarningsPerShareBasic $ (0.08)us-gaap_EarningsPerShareBasic
Diluted (in dollars per share) $ 0.11us-gaap_EarningsPerShareDiluted $ (0.79)us-gaap_EarningsPerShareDiluted $ (0.08)us-gaap_EarningsPerShareDiluted
Weighted average common shares outstanding:      
Basic (in shares) 35,990,122us-gaap_WeightedAverageNumberOfSharesIssuedBasic 33,141,500us-gaap_WeightedAverageNumberOfSharesIssuedBasic 33,141,500us-gaap_WeightedAverageNumberOfSharesIssuedBasic
Diluted (in shares) 38,535,325us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 33,141,500us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 33,141,500us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Pro Forma Data (Note 2)      
Other income (expense):      
Income (loss) before income taxes 9,206us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
(26,120)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
(2,639)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
Income tax expense (2,189)us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
(2,911)us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
(1,558)us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
Net income (loss) 7,017us-gaap_ProfitLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
(29,031)us-gaap_ProfitLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
(4,197)us-gaap_ProfitLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
Less: net loss attributable to noncontrolling interest (225)us-gaap_NetIncomeLossAttributableToNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
   
Net income (loss) attributable to Diplomat Pharmacy, Inc. 7,242us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
(29,031)us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
(4,197)us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
Net income allocable to preferred shareholders 694dplo_NetIncomeLossAvailableToPreferredStockholders
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
   
Net income (loss) allocable to common shareholders $ 6,548us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
$ (29,031)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
$ (4,197)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
Net income (loss) per common share:      
Basic (in dollars per share) $ 0.18us-gaap_BasicEarningsPerShareProForma
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
$ (0.88)us-gaap_BasicEarningsPerShareProForma
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
$ (0.13)us-gaap_BasicEarningsPerShareProForma
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
Diluted (in dollars per share) $ 0.17us-gaap_DilutedEarningsPerShareProForma
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
$ (0.88)us-gaap_DilutedEarningsPerShareProForma
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember
$ (0.13)us-gaap_DilutedEarningsPerShareProForma
/ us-gaap_StatementScenarioAxis
= us-gaap_ProFormaMember